Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma

Experimental and Molecular Pathology

Volumn 90, Issue 2, 2011, Pages 179-188

  Rath, Prakash ^a,e   Miller, Douglas C ^b   Litofsky, N Scott ^b   Anthony, Douglas C ^b   Feng, Qi ^b   Franklin, Craig ^c   Pei, Lirong ^d   Free, Alan ^d   Liu, Jimei ^d   Ren, Mingqiang ^d   Kirk, Mark D ^a   Shi, Huidong ^d  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Atypical meningioma; Malignant progression; Microarray; Molecular genetics; Progenitor cell

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CELL PROTEIN; HERMES ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GENETICS; CANCER STEM CELL; CDKN2A GENE; CDKN2B GENE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL RENEWAL; CELL TYPE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MENINGIOMA; MENINGIOMA INITIATING CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; P14ARF GENE; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; ANTIGENS, CD44; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MESODERM; MICE; MICE, NUDE; MITOGENS; NEOPLASTIC STEM CELLS; NEUROGLIA; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 78651237413     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.12.003     Document Type: Article

References (35)

1. Bleau A.M., et al. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg. Focus 2008, 24:E28.
2. Bostrom J., et al. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am. J. Pathol. 2001, 159:661-669.
3. CBTRUS Statistical Report: Primary Brain Tumors in the United States 2007-2008, Central Brain Tumor Registry of the United States of America, C., IL.
4. Chu P., et al. Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int. J. Cancer 2009, 124:1312-1321.
5. Dalerba P., et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl Acad. Sci. USA 2007, 104:10158-10163.
6. DiMeo T.A., et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res. 2009, 69:5364-5373.
7. Fabian A., et al. Die hard: are cancer stem cells the Bruce Willises of tumor biology?. Cytom. A 2009, 75:67-74.
8. Fang D., et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005, 65:9328-9337.
9. Hanemann C.O. Magic but treatable? Tumours due to loss of merlin. Brain 2008, 131:606-615.
10. Hill R., Wu H. PTEN, stem cells, and cancer stem cells. J. Biol. Chem. 2009, 284:11755-11759.
11. Hueng D.Y., et al. Isolation and characterization of tumor stem-like cells from human meningiomas. J. Neurooncol. 2010.
12. Ikeda H., Yoshimoto T. Immunohistochemical study of anaplastic meningioma with special reference to the phenotypic change of intermediate filament protein. Ann. Diagn. Pathol. 2003, 7:214-222.
13. Keller A., et al. Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int. J. Cancer 2009, 124:346-351.
14. Klein W.M., et al. Increased expression of stem cell markers in malignant melanoma. Mod. Pathol. 2007, 20:102-107.
15. Lapidot T., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
16. Liu Y., et al. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum. Pathol. 2005, 36:416-425.
17. Lunter P.C., et al. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Cancer Res. 2005, 65:8801-8808.
18. Mani S.A., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
19. Medici D., et al. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol. Biol. Cell 2008, 19:4875-4887.
20. Patrawala L., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
21. Perry A. Menigiomas. Russell and Rubinstein's Pathology of Tumors of the Nervous System 2006, 427-474. Hodder Arnold, London. R.M. McLendon RE, D.D. Bigner (Eds.).
22. Perry A.L.D., Scheithauer B.W., Budka H., von Deimling A. Menigiomas. WHO Classification of Tumours of the Central Nervous System 2007, International Agency for Research on Cancer, Lyon, France. O.H. Louis DN, O.D. Wiestler, W.K. Cavenee (Eds.).
23. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
24. Ragel B.T., et al. A comparison of the cell lines used in meningioma research. Surg. Neurol. 2008, 70:295-307. discussion 307.
25. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
26. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
27. Sasaki T., et al. Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip. Neurosurgery 2003, 52:892-898. discussion 898-9.
28. Simon M., et al. Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery 2007, 60:787-798. discussion 787-98.
29. Singh S.K., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
30. Singh S.K., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
31. Watson M.A., et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am. J. Pathol. 2002, 161:665-672.
32. Weber R.G., et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc. Natl Acad. Sci. USA 1997, 94:14719-14724.
33. Willis J., et al. The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol. Appl. Neurobiol. 2005, 31:141-149.
34. Wrobel G., et al. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int. J. Cancer 2005, 114:249-256.
35. Zhang S., et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68:4311-4320.